Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01162213 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Lychee Fruit Extract to Promote Cardiovascular Health
A Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT01162213 is a Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 44 participants.
The verdict
NCT01162213, a Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
The investigators hypothesize that acute and short term consumption of a lychee fruit extract, particularly rich in low molecular weight dietary flavanols, will improve vascular function and reduce platelet reactivity.
Interventions
- DIETARY_SUPPLEMENT Lychee Fruit Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01162213
The ClinicalTrials.gov registry entry for NCT01162213 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lychee Fruit Extract is the first listed.
NCT01162213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01162213 about?
NCT01162213 is a clinical study titled "Pilot Study of Lychee Fruit Extract to Promote Cardiovascular Health". The investigators hypothesize that acute and short term consumption of a lychee fruit extract, particularly rich in low molecular weight dietary flavanols, will improve vascular function and reduce platelet reactivity.
What is the current status of trial NCT01162213?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2009-04. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01162213?
The interventions under investigation include: Lychee Fruit Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01162213?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.